Back
BNP Paribas Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
77
BNPQY
BNP Paribas
Last Price:
$44.29
Seasonality Move:
1.19%
Sell
31
CRSP
CRISPR Therapeutics AG
Last Price:
$37.24
Seasonality Move:
22.33%
Buy
77
BNP Paribas (BNPQY)
is a Buy
Is BNP Paribas a Buy, Sell or Hold?
-
The current BNP Paribas [BNPQY] share price is $44.29. The Score for BNPQY is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
BNPQY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $37.22. The Score for CRSP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BNPQY Stock Price Chart
What is BNP Paribas's stock price today?
-
The BNP Paribas share price today is $44.29Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BNPQY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $37.22Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
BNPQY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.99 | Buy |
| Relative Strength Index (14 RSI): | 65.64 | Buy |
| Chaikin Money Flow: | 149986 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.16 - 43.56) | Buy |
| Bollinger Bands (100): | (32.64 - 42.1) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.76 | Buy |
| Relative Strength Index (14 RSI): | 49.84 | Sell |
| Chaikin Money Flow: | 315093 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.06 - 39.14) | Buy |
| Bollinger Bands (100): | (36.48 - 44.34) | Sell |
BNPQY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.54 | Buy |
| 20-day SMA: | 42.22 | Buy |
| 50-day SMA: | 41.42 | Buy |
| 200-day SMA: | 35.41 | Buy |
| 8-day EMA: | 43.48 | Buy |
| 20-day EMA: | 42.46 | Buy |
| 50-day EMA: | 40.8 | Buy |
| 200-day EMA: | 36.6 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.23 | Buy |
| 20-day SMA: | 37.45 | Sell |
| 50-day SMA: | 38.42 | Sell |
| 200-day SMA: | 44.63 | Sell |
| 8-day EMA: | 36.62 | Buy |
| 20-day EMA: | 36.02 | Buy |
| 50-day EMA: | 28.85 | Buy |
| 200-day EMA: | 11.69 | Buy |
BNP Paribas Earnings Growth & BNPQY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.24 per share, and an increase next year of $1.00 per share.
BNP Paribas Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||